###begin article-title 0
###xml 74 80 <span type="species:ncbi:10090">Murine</span>
###xml 85 90 <span type="species:ncbi:9606">Human</span>
H4 Histamine Receptors Mediate Cell Cycle Arrest in Growth Factor-Induced Murine and Human Hematopoietic Progenitor Cells
###end article-title 0
###begin p 1
Conceived and designed the experiments: ES MD. Performed the experiments: AFPB FM. Analyzed the data: AFPB PM ES MD. Contributed reagents/materials/analysis tools: MPD MG PC PM. Wrote the paper: ES MD.
###end p 1
###begin p 2
###xml 905 913 905 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 186 192 <span type="species:ncbi:10090">murine</span>
###xml 197 202 <span type="species:ncbi:9606">human</span>
###xml 803 809 <span type="species:ncbi:10090">murine</span>
###xml 814 819 <span type="species:ncbi:9606">human</span>
###xml 939 945 <span type="species:ncbi:10090">murine</span>
The most recently characterized H4 histamine receptor (H4R) is expressed preferentially in the bone marrow, raising the question of its role during hematopoiesis. Here we show that both murine and human progenitor cell populations express this receptor subtype on transcriptional and protein levels and respond to its agonists by reduced growth factor-induced cell cycle progression that leads to decreased myeloid, erythroid and lymphoid colony formation. H4R activation prevents the induction of cell cycle genes through a cAMP/PKA-dependent pathway that is not associated with apoptosis. It is mediated specifically through H4R signaling since gene silencing or treatment with selective antagonists restores normal cell cycle progression. The arrest of growth factor-induced G1/S transition protects murine and human progenitor cells from the toxicity of the cell cycle-dependent anticancer drug Ara-C in vitro and reduces aplasia in a murine model of chemotherapy. This first evidence for functional H4R expression in hematopoietic progenitors opens new therapeutic perspectives for alleviating hematotoxic side effects of antineoplastic drugs.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 160 163 160 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Schneider1">[1]</xref>
###xml 164 167 164 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Jutel1">[3]</xref>
###xml 370 373 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Hough1">[4]</xref>
###xml 374 377 374 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Labella1">[6]</xref>
###xml 562 565 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Jutel2">[7]</xref>
###xml 567 570 567 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Miyoshi1">[8]</xref>
Histamine is one of the most versatile biogenic amines with pleiotropic activities, including regulatory functions during the immune response and hematopoiesis [1]-[3]. This functional diversity results from the variety of its modes of intervention through extra- and intracellular binding sites and specific receptors, triggering different signal transduction pathways [4]-[6]. The final outcome of these interactions is quite complex, as it depends on how receptors are distributed on target cells, according to their microenvironment and stage of development [7], [8].
###end p 4
###begin p 5
###xml 89 92 89 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Liu1">[9]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Buckland1">[10]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Gutzmer1">[14]</xref>
###xml 464 468 464 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Gantner1">[15]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Dunford1">[16]</xref>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-deEsch1">[17]</xref>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
Even though the most recently discovered H4R is mainly expressed in the bone marrow (BM) [9], its potential role during hematopoiesis has not been addressed. To date, its most clearly established functions consist in recruitment and activation of hematopoietic cells involved in inflammatory responses, such as eosinophils, mast cells, neutrophils and dendritic cells [10]-[14]. Because of these activities, together with H4R-induced IL-16 production by CD8 cells [15] and alleviation of experimental allergic asthma in H4R-deficient mice [16], this receptor is considered a potential pharmacological target for anti-inflammatory therapy [17].
###end p 5
###begin p 6
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Byron1">[18]</xref>
###xml 151 155 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Schneider3">[19]</xref>
###xml 491 497 <span type="species:ncbi:10090">murine</span>
###xml 502 507 <span type="species:ncbi:9606">human</span>
###xml 884 890 <span type="species:ncbi:10090">murine</span>
Histamine has been implicated in the regulation of hematopoietic progenitor cells by several studies, including those of J. W. Byron and our own [18], [19]. These activities have been ascribed to H1 and H2 histamine receptors, the only subtypes known at the time. The discovery of an additional H4R, together with its predominant expression in the bone marrow, prompted us to reassess this issue. Here we report that the H4R is preferentially expressed and functional in progenitor-enriched murine and human hematopoietic cells, as it mediates a reversible cAMP/PKA-dependent cell cycle arrest that causes reduced proliferation and colony formation in methylcellulose. Based on the notion that quiescence protects clonogenic cells from growth-dependent cytotoxicity, we investigated whether H4R activation could become instrumental in a clinical setting to prevent myeloablation in a murine model of chemotherapy.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 29 35 <span type="species:ncbi:10090">murine</span>
Functional H4R expression in murine hematopoietic progenitor cells
###end title 8
###begin p 9
###xml 150 157 150 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 150 157 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g001"><bold>Fig. 1A</bold></xref>
###xml 244 245 244 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 275 276 275 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 364 370 <span type="species:ncbi:10090">Murine</span>
We assessed the expression of the H4R in total and progenitor-enriched bone marrow (BM) populations by staining with specific antibodies. As shown in Fig. 1A, the proportion of positive cells increased from total BM to progenitor-enriched c-kit+ and more primitive c-kit+Sca1+ cells, which proved that the receptor is mainly expressed in the immature compartment. Murine bone marrow-derived mast cells are shown as a positive control.
###end p 9
###begin title 10
###xml 29 35 <span type="species:ncbi:10090">murine</span>
Functional H4R expression in murine hematopoietic progenitor cells.
###end title 10
###begin p 11
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 51 52 51 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 297 298 297 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 453 455 453 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 644 645 644 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1072 1073 1070 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1197 1199 1195 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1252 1254 1250 1252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1317 1318 1313 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 192 198 <span type="species:ncbi:10090">murine</span>
(A) Staining of total, sorted c-kit+ and c-kit+Sca1+ BM cells with anti-H4R antibody compared with irrelevant isotype control and anti-H4R antibody saturated with blocking peptide. BM-derived murine mast cells served as a positive control. (B) Cell cycle arrest in sorted progenitor-enriched c-kit+ BM cells after a 2-h incubation in StemSpan medium supplemented with growth factor cocktail (GF), with or without histamine or CB at a concentration of 10-5 M. The cell cycle status was analyzed after staining with Vybrant DyeCycle Violet (VDV) as compared with freshly isolated cells. (C) Reversal of H4R-induced cell cycle arrest. Sorted c-kit+ cells were incubated for 3 days with or without CB in StemSpan medium supplemented with growth factor cocktail. The cell cycle status was then assessed before and after further incubation of extensively washed cells with growth factors for 24 h. Data are means+/-SD from 2 experiments. Unstained apoptotic cells were not detected. (D) Recovery of normal cell cycling in the presence of a selective H4R antagonist. Sorted c-kit+ BMC were incubated for 3 days with growth factors (GF) alone or together with histamine (HA) or CB at a concentration of 10-5 M, with or without prior exposure to JNJ 7777120 (10-5 M). Means+/-SEM from 3 experiments. (E) H4R silencing in c-kit+ BM cells. H4R expression was evaluated 24 h after transfection (>90% efficiency). The effect of gene silencing on CB-induced cell cycle arrest was assessed following overnight incubation. Means+/-SEM from 3 experiments.
###end p 11
###begin p 12
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 307 314 307 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1B</bold>
###xml 307 314 307 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g001"><bold>Fig. 1B</bold></xref>
###xml 353 354 353 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 554 556 554 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 583 592 583 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006504.s001">Figure S1</xref>
###xml 583 592 583 592 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0006504.s001">Figure S1</xref></bold>
###xml 649 650 649 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 652 653 652 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 671 672 671 672 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 829 836 829 836 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1C</bold>
###xml 829 836 829 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g001"><bold>Fig. 1C</bold></xref>
###xml 979 988 979 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006504.s002">Figure S2</xref>
###xml 979 988 979 988 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0006504.s002">Figure S2</xref></bold>
We evaluated the function of the H4R, by examining the effect of histamine, its natural ligand, and clobenpropit (CB), one of its most potent agonists, on the cell cycle status of sorted c-kit+ BM cells, which comprise a heterogenous population of progenitors at various differentiation stages. As shown in Fig. 1B, these cells are mostly quiescent at t0, but enter the cell cycle in response to a growth factor cocktail composed of IL-3, IL-6 and SCF. Both histamine and CB inhibited growth factor-induced cell cycle progression at an optimal dose of 10-5 M (dose-response curve in Figure S1), as illustrated by the accumulation of cells in stage G0/G1 and decrease in G2/S. The cell cycle arrest persisted after 3 days in the presence of CB, but could by reversed upon its removal by a 24-h exposure to growth factor cocktail (Fig. 1C). Apoptosis was not induced in these conditions, as assessed by Annexin-V/PI staining illustrated by the dot plots of a typical experiment in Figure S2.
###end p 12
###begin p 13
###xml 110 113 110 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Schneider2">[5]</xref>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Thurmond1">[20]</xref>
###xml 214 221 214 221 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1D</bold>
###xml 214 221 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g001"><bold>Fig. 1D</bold></xref>
###xml 425 434 425 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006504.s003">Figure S3</xref>
###xml 425 434 425 434 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="supplementary-material" rid="pone.0006504.s003">Figure S3</xref></bold>
###xml 531 532 531 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 617 624 617 624 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1E</bold>
###xml 617 624 617 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g001"><bold>Fig. 1E</bold></xref>
Though initially developed as an H3R antagonist, CB is H4R-specific in BM cells, which do not express the H3R [5]. Pretreatment with the selective H4R antagonist JNJ7777120 [20] before exposure to histamine or CB (Fig. 1D) prevented the cell cycle arrest, providing an additional argument in favor of H4R specificity. This was confirmed by a similar effect of the antagonist JNJ10191585 and the reverse agonist thioperamide (Figure S3). Finally, growth factor-induced cell cycle progression was restored in progenitor-enriched ckit+ BM cells transfected with siRNA to knock down H4R expression before exposure to CB (Fig. 1E). This treatment did effectively diminish H4R expression on protein levels, proving the specificity of the effect.
###end p 13
###begin title 14
H4R-mediated inhibition of cell proliferation and/or differentiation of clonogenic progenitors
###end title 14
###begin p 15
###xml 255 256 255 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 303 310 303 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2A</bold>
###xml 303 310 303 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g002"><bold>Fig. 2A</bold></xref>
###xml 384 391 384 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2B</bold>
###xml 384 391 384 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g002"><bold>Fig. 2B</bold></xref>
###xml 523 524 523 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 528 529 528 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 687 694 683 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 1A</bold>
###xml 687 694 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g001"><bold>Fig. 1A</bold></xref>
###xml 709 716 705 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 709 716 705 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g002"><bold>Fig. 2C</bold></xref>
###xml 1075 1082 1071 1078 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 2C</bold>
###xml 1075 1082 1071 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g002"><bold>Fig. 2C</bold></xref>
The inhibition of growth factor-induced G1/S transition in the presence of CB led to reduced proliferation and/or differentiation, as revealed 1) by the maintenance of c-kit expression among progenitor-enriched cells depleted for mature BM components (Lin-) after a 3-day culture in the presence of CB (Fig. 2A) and 2) by a reduced number of cell divisions measured by CFSE tracking (Fig. 2B), relative to growth factor-stimulated controls. H4R activation inhibited likewise the proliferation of more primitive sorted c-kit+Sca1+ cells (78+/-5% inhibition in response to CB after 3 days of culture with growth factor cocktail; mean+/-SEM; n = 3), in agreement with their H4R expression (Fig. 1A). As shown in Fig. 2C, it caused a marked decrease in both myeloid (CFU-GM) and lymphoid (CLP) colony formation in methylcellulose. A comparable inhibition occurred in the HALO-Hemogenix luminescence assay, set up with different growth factor cocktails to reveal proliferation of progenitors with distinct differentiation potentials (CFU-C, CFU-C+BFU-E and CFU-C+BFU-E+CFU-GEMM) (Fig. 2C). Once again, the H4R antagonist JNJ7777120 reversed the inhibition of CB on IL-3-induced colony formation (10.5+/-5.1% in the presence of JNJ versus 55.1+/-10.3% in response to CB alone; n = 3).
###end p 15
###begin title 16
H4R-mediated inhibition of clonogenic cell proliferation and/or differentiation.
###end title 16
###begin p 17
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</sup>
###xml 120 122 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 149 150 149 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 428 429 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 471 472 469 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 483 484 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 860 862 858 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 1006 1008 1002 1004 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
(A) Maintenance of c-kit expression by Lin- BMC incubated for 3 days in growth factor cocktail (GF) together with CB (10-5 M), as compared with c-kit+ cells freshly sorted or cultured in GF alone. (B) Decreased number of cell divisions upon H4R stimulation. After staining with CFSE, Lin- BM cells were incubated for 3 days in growth factor cocktail with or without CB. CFSE fluorescence intensity was analyzed among gated c-kit+ cells. (Means+/-SEM from 6 experiments. *P = 0.013 **P = 0.0022). A typical FACS profile is shown. (C) Inhibition of colony formation from total BM cells in the presence of CB. Cells were seeded into MethoCult supplemented with 1 ng/ml of mrIL-3 to generate granulocyte/macrophage colonies or with SCF (100 ng/ml)+IL-7 (10 ng/ml+Flt-3-L (20 ng/ml) to reveal common lymphoid progenitors (CLP). CB was added at a concentration of 10-5 M and colonies were scored after 7 days of culture. Means+/-SEM. from 3 experiments. The right panel depicts the results obtained with the HALOTM-Hemogenix assay based on luminescence output in response to growth factor cocktails revealing CFU-GM, CFU-GM+BFU-E and CFU-GM+BFU-E+CFU-GEMM. Means+/-SEM from quadruplicate determinations.
###end p 17
###begin title 18
Impaired expression of cell cycle proteins through cAMP/PKA-dependent signaling triggered by H4R engagement
###end title 18
###begin p 19
###xml 110 117 110 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3A</bold>
###xml 110 117 110 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g003"><bold>Fig. 3A</bold></xref>
###xml 374 378 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Kozar1">[21]</xref>
###xml 511 524 509 522 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3B and C</bold>
###xml 511 524 509 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g003"><bold>Fig. 3B and C</bold></xref>
###xml 661 670 659 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1/Waf1</sup>
###xml 681 685 679 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 712 719 710 717 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 3C</bold>
###xml 712 719 710 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g003"><bold>Fig. 3C</bold></xref>
We examined the impact of H4R activation on the expression of genes encoding cell cycle proteins. As shown in Fig. 3A, the overall transcription of growth factor-induced cell cycle genes (oligo GEArray(R) 0MM-020) decreased strikingly upon exposure to CB, almost to the level of freshly isolated cells. Further analysis of cyclins expressed typically during G1/S transition [21] established that both cyclin D3 and E were markedly decreased in response to CB, as demonstrated by FACS and Western blot analysis (Fig. 3B and C, respectively). In addition, the H4R agonist prevented growth factor-induced downregulation of the cyclin-dependent kinase inhibitor p21Cip1/Waf1, while p27Kip1 expression was decreased (Fig. 3C).
###end p 19
###begin title 20
H4R activation impairs the expression of cell cycle proteins.
###end title 20
###begin p 21
###xml 20 22 20 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 427 428 427 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 665 666 663 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A) The effect of 10-5 M CB on the expression of cell cycle genes was assessed in freshly isolated c-kit+ BM cells and after a 3-h exposure to growth factor cocktail (GF) with or without CB, using a cell cycle Oligo GEArray. Fold decrease upon exposure to CB: 35 for cyclin D3: and: 54 for cyclin E. (B) Decreased intracellular staining with FITC-conjugated anti-cyclin D3 antibody after an overnight incubation of sorted c-kit+ cells in the presence of CB, as compared with growth factors alone. Data represent a typical dot plot and means+/-SEM from 3 experiments. (C) Western blot analysis in whole-cell extracts before and after a 5-h incubation of sorted c-kit+ cells with growth factors alone or together with CB.
###end p 21
###begin p 22
###xml 83 103 83 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 153 156 153 156 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 228 235 228 235 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4A</bold>
###xml 228 235 228 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g004"><bold>Fig. 4A</bold></xref>
###xml 413 420 413 420 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4B</bold>
###xml 413 420 413 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g004"><bold>Fig. 4B</bold></xref>
###xml 591 598 591 598 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4C</bold>
###xml 591 598 591 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g004"><bold>Fig. 4C</bold></xref>
###xml 746 750 746 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Stork1">[22]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Cheng1">[23]</xref>
###xml 903 910 903 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 4D</bold>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g004"><bold>Fig. 4D</bold></xref>
###xml 83 103 <span type="species:ncbi:520">Bordetella pertussis</span>
CB did no longer inhibit cell cycling in progenitor-enriched BM cells treated with Bordetella pertussis toxin (PTX), which confirmed the involvement of Gi/o protein coupling in the initiation of the signal transduction pathway (Fig. 4A). The decrease of intracellular cAMP levels is critical for cell cycle arrest that is counteracted by adding exogenous dbcAMP, a cell-permeable analogue of this signal carrier (Fig. 4B). In further support of this mechanism of action, CB inhibited cell cycle progression induced by forskolin, commonly used to raise intracellular cAMP levels. As shown in Fig. 4C, it did not affect the expression of Erk, conversely to other models in which a crosstalk between cAMP and the ERK/MAPK pathway has been described [22]. The PKA/CREB pathway is the most likely candidate for downstream signaling [23], given that the PKA inhibitor Rp-8-Br-cAMPS mimicked the effect of CB (Fig. 4D).
###end p 22
###begin title 23
###xml 50 53 50 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
CB-induced cell cycle arrest is mediated through Gi/o proteins and cAMP/PKA-dependent signaling.
###end title 23
###begin p 24
###xml 16 17 16 17 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 349 350 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 450 452 448 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 755 756 751 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 938 939 934 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
(A) Sorted c-kit+ BM cells were exposed for 2 h to growth factor cocktail with or without CB and/or PTX (100 ng/ml). The cell cycle status was analyzed after staining with Vybrant DyeCycle Violet (VDV), in comparison with freshly isolated cells. Means+/-SEM from 3 experiments. (B) Critical role of cAMP in CB-induced cell cycle arrest. Sorted c-kit+ BM cells were incubated for 2 h in StemSpan medium with growth factor cocktail or forskolin (FK; 10-5 M) with or without CB, dbcAMP alone or together with growth factors and CB. The cell cycle status was assessed by Vybrant DyeCycle Violet (VDV) staining. Data represent typical cell cycle profiles and means+/-SEM from 3 experiments. (C) Western blot analysis of Erk expression in freshly isolated c-kit+ cells and after 5 h of incubation with growth factor cocktail (GF) with or without CB. (D) The PKA inhibitor Rp-8-Br-cAMPS mimics the cell cycle arrest induced by CB in sorted c-kit+ BM cells stimulated with growth factor cocktail. The cell cycle status was evaluated by VDV staining after a 2-h incubation.
###end p 24
###begin title 25
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 26 33 26 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 48 54 <span type="species:ncbi:10090">murine</span>
H4R-mediated in vitro and in vivo protection of murine hematopoietic progenitor cells against the toxicity of anti-cancer drugs
###end title 25
###begin p 26
###xml 171 179 171 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 504 511 504 511 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5A</bold>
###xml 504 511 504 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g005"><bold>Fig. 5A</bold></xref>
###xml 629 636 629 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 756 763 756 763 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5B</bold>
###xml 756 763 756 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g005"><bold>Fig. 5B</bold></xref>
###xml 845 846 845 846 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 866 867 866 867 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 869 870 869 870 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 195 201 <span type="species:ncbi:10090">murine</span>
###xml 698 702 <span type="species:ncbi:10090">mice</span>
###xml 941 945 <span type="species:ncbi:10090">mice</span>
We argued that H4R-induced cell cycle arrest, which is reversible and not associated with apoptosis, might provide a strategy for myeloprotection. To test this assumption in vitro, we pretreated murine BM cells with or without CB, before stimulating their entry into cell cycle in response to growth factors, followed by exposure to the cell cycle-dependent anti-cancer drugs AraC or hydroxy-urea (HU). We then assessed their clonogenic potential in the methylcellulose colony-forming assay, as shown in Fig. 5A. We found that this treatment protected a substantial proportion of clonogenic progenitors, which opened the way for in vivo experiments, to verify whether cell cycle arrest occurred in mice having received repeat injections of CB. As shown in Fig. 5B, this turned out to be the case since the proportion of progenitor-enriched c-kit+ BM cells in phase G0/G1 of the cell cycle was significantly higher among cells recovered from mice having received CB before stimulation with growth factor cocktail than among their saline-injected counterpart.
###end p 26
###begin title 27
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 33 39 <span type="species:ncbi:10090">murine</span>
H4R-induced cell cycle arrest in murine hematopoietic progenitors in vivo and protection against the cytotoxicity of cell cycle-dependent chemotherapeutic compounds.
###end title 27
###begin p 28
###xml 110 112 106 108 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 479 480 475 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 501 509 497 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 722 726 <span type="species:ncbi:10090">mice</span>
###xml 851 855 <span type="species:ncbi:10090">mice</span>
###xml 892 896 <span type="species:ncbi:10090">mice</span>
(A) BM cells were pretreated for 24 h with CB, before exposure to AraC (10 microg/ml), or hydroxy-urea (HU; 10-3 M). After a 1-h incubation, cells were extensively washed and plated in methylcellulose in the presence of IL-3 (1 ng/ml). 7 days later colonies were scored and survival with or without CB was evaluated relative to saline controls. (B) BM cells were recovered 4 h after the last of three injections of CB or saline (30 mg/kg each). The cell cycle status of gated Lin- cells was evaluated in vitro after exposure to growth factors overnight (means+/-SEM; n = 3). (C) Injection schedule of CB in AraC- or cyclophosphamide-treated mice. (D-G) Total WB and BM cells were counted 2 days after injection of AraC in mice having received 3 i.p. injections of CB (20 mg/kg each) or saline, as compared with CB alone, Means+/-SEM from 8 individual mice. CFU-GM were evaluated in the BM of mice having received AraC or cyclophosphamide 2 days before sacrifice. Data are means+/-SEM. n = 8 and n = 2 in the AraC and cyclophosphamide series.
###end p 28
###begin p 29
###xml 138 145 138 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5C</bold>
###xml 138 145 138 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g005"><bold>Fig. 5C</bold></xref>
###xml 256 269 256 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5D and E</bold>
###xml 256 269 256 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g005"><bold>Fig. 5D and E</bold></xref>
###xml 356 363 356 363 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5F</bold>
###xml 356 363 356 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g005"><bold>Fig. 5F</bold></xref>
###xml 447 456 447 456 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5D-F</bold>
###xml 447 456 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g005"><bold>Fig. 5D-F</bold></xref>
###xml 761 768 761 768 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 5E</bold>
###xml 761 768 761 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g005"><bold>Fig. 5E</bold></xref>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
We assessed myeloprotection through H4R activation in a model of cell cycle-dependent chemotherapy, following the schedule represented in Fig. 5C. At day 2 post AraC CB maintained significantly higher BM and white blood cell counts relative to AraC alone (Fig. 5D and E). This was likewise true for clonogenic cells evaluated in the methylcellulose assay (Fig. 5F). Treatment with CB alone had no significant effect on either of these parameters (Fig. 5D-F) and had no other adverse consequences. Following the same injection schedule, CB provided also a partial protection of medullary colony-forming cells 2 days post treatment of mice with the antineoplastic drug cyclophosphamide (300 mg/kg), a mobilizing agent that is only partially cell cycle-dependent (Fig. 5E).
###end p 29
###begin title 30
###xml 33 38 <span type="species:ncbi:9606">human</span>
H4R-induced cell cycle arrest in human hematopoietic progenitor cells
###end title 30
###begin p 31
###xml 129 136 129 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6A</bold>
###xml 129 136 129 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g006"><bold>Fig. 6A</bold></xref>
###xml 160 164 160 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">high</sup>
###xml 415 416 413 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 486 487 482 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 550 551 546 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 729 736 723 730 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6B</bold>
###xml 729 736 723 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g006"><bold>Fig. 6B</bold></xref>
###xml 819 820 813 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 822 823 816 817 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 825 832 819 826 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6C</bold>
###xml 825 832 819 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g006"><bold>Fig. 6C</bold></xref>
###xml 1083 1084 1077 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1131 1138 1125 1132 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6D</bold>
###xml 1131 1138 1125 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g006"><bold>Fig. 6D</bold></xref>
###xml 1385 1392 1379 1386 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 6E</bold>
###xml 1385 1392 1379 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g006"><bold>Fig. 6E</bold></xref>
###xml 79 84 <span type="species:ncbi:9606">human</span>
###xml 953 959 <span type="species:ncbi:10090">murine</span>
We addressed the question whether the H4R was also expressed and functional in human hematopoietic progenitor cells. As shown in Fig. 6A, the most immature CD34high cells isolated from cord blood and expanded for 3 days in growth factor cocktail were largely H4R-positive. Furthermore, their proliferation in response to the growth factor cocktail was clearly inhibited upon exposure to the agonist CB (3.8+/-1.4x106 cells in response to growth factor cocktail alone versus 1.8+/-0.9x106 in the presence of CB after 3 days of culture starting from 106 cells; means+/-SEM; n = 5), in accordance with an induction of the cell cycle arrest. Indeed, H4R activation decreased the number of cell divisions, evaluated by CFSE staining (Fig. 6B) and slowed down cell cycle progression by increasing the percentage of cells in G0/G1 (Fig. 6C). Cell viability, determined by trypan blue exclusion and FACS analysis was not impaired in these conditions. As in the murine model, H4R specificity was established by gene silencing that abolished most of the anti-proliferative effect of CB on CD34+ cells stimulated with growth factor cocktail (Fig. 6D). A similar restoration of cell growth occurred after receptor blockade by JNJ7777120 (data not shown). Finally, a 24-h pretreatment with CB before exposure to AraC was clearly protective, supporting potential applications in a clinical setting (Fig. 6E).
###end p 31
###begin title 32
###xml 63 68 <span type="species:ncbi:9606">human</span>
H4R activation induces inhibition of cell cycle progression in human progenitor cells.
###end title 32
###begin p 33
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 216 217 216 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 463 464 463 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 683 684 681 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1112 1113 1108 1109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1055 1060 <span type="species:ncbi:9606">human</span>
(A) H4R expression in gated CD34+ cells sorted from cord blood after a 3-day expansion in StemSpan medium with growth factor cocktail. (B) Tracking of cell divisions by CFSE staining. After expansion for 3 days, CD34+ were stained with CFSE and incubated for further 3 days in StemSpan medium supplemented with growth factor cocktail with or without CB. They were then labeled with PE-conjugated CD34 mAb and CFSE fluorescence intensity was measured in gated CD34+ cells. Data represent a typical experiment out of 2. (C) Cell cycle analysis. Cells were prepared as above, followed by staining with FITC-conjugated anti-CD34 mAb and PI. (Means+/-SEM; n = 3. (D) H4R silencing in CD34+ cells. H4R expression was evaluated 24 h after transfection (>90% efficiency) with silencing and scrambled RNA. The effect of gene silencing on CB-induced inhibition of proliferation was assessed after a further 3-day incubation when cells were counted and viability was assessed by trypan blue exclusion. Data represent means+/-SD from 2 experiments. (E) Protection of human clonogenic cells against the toxicity of AraC. CD34+ cells were pretreated for 24 h with CB, before exposure to AraC (10 microg/ml). After a 1-h incubation, cells were extensively washed and plated in methylcellulose supplemented with growth factor cocktail. 14 days later colonies were scored and survival with or without CB was evaluated relative to saline controls. (Means+/-SEM; n = 3).
###end p 33
###begin title 34
H4R expression and function in cancer cell lines
###end title 34
###begin p 35
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Cianchi1">[24]</xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Medina1">[25]</xref>
###xml 395 397 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 436 443 436 443 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7A</bold>
###xml 436 443 436 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g007"><bold>Fig. 7A</bold></xref>
###xml 559 566 559 566 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fig. 7B</bold>
###xml 559 566 559 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006504-g007"><bold>Fig. 7B</bold></xref>
###xml 159 164 <span type="species:ncbi:9606">human</span>
It is generally acknowledged the H4R expression occurs mainly in cells of hematopoietic origin. Nevertheless, the receptor has been reported in two well-known human colon cancer cell lines, HT29 and HCT116, and the mammary carcinoma MDA-MB-231 [24], [25], prompting us to verify whether the H4R agonist CB inhibited their proliferation, which was not the case since at optimal concentrations (10-5 M) neither the growth of these cells (Fig. 7A) nor their sensitivity to the anti-neoplastic drug 5-FU were affected, as illustrated for the HCT 116 cell line in Fig. 7B. However, this result is not conclusive, inasmuch as we were unable to confirm the H4R expression on transcriptional and protein levels reported before (data not shown), which shows that it is indeed essential to assess whether H4R is operational in the cancer cells each time before considering a clinical application.
###end p 35
###begin title 36
Malignant cell proliferation and sensitivity to 5-FU are not affected by C.
###end title 36
###begin p 37
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 331 332 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 368 370 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
(A) Proliferation of colon and mammary gland carcinoma cells was assessed after 3 days of culture starting from 2x105 cells in 1 ml. Cells were detached by trypsin digestion and counted after staining with trypan blue. Data are means+/-SEM from three distinct experiments. (B) HCT116 carcinoma cells set up at a concentration of 105/ml were pretreated 24 h with CB (10-5 M) before adding 5-FU (Sigma) at a concentration of 10 microg/ml for 48 h. 2 typical experiments are shown.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 370 373 370 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Schneider2">[5]</xref>
###xml 78 84 <span type="species:ncbi:10090">murine</span>
###xml 89 94 <span type="species:ncbi:9606">human</span>
In this study we provide the first demonstration that the H4R is expressed in murine and human hematopoietic progenitor cells and that its activation results in the inhibition of growth factor-induced cell cycling. In our experimental setup histamine and CB, which is also a H3R antagonist, target the H4R specifically, since 1) bone marrow cells do not express the H3R [5], 2) cell cycle progression was restored when the H4R was blocked by selective H4R antagonists before exposure to CB or histamine and 3) the effect of CB was clearly reduced after H4R silencing. The H4R is functional in hematopoietic progenitor cells since its stimulation inhibited both myeloid and lymphoid colony formation, suggesting a relatively broad distribution among different progenitor subsets identified by their distinct clonogenic potential.
###end p 39
###begin p 40
###xml 98 101 98 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i/o</sub>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Stork1">[22]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Cheng1">[23]</xref>
The signal transduction pathway leading from H4R engagement to cell cycle arrest is initiated by Gi/o protein coupling followed by a decrease of cAMP levels. Further downstream, it entails downregulation of PKA activity since a specific inhibitor of this enzyme mimicked the effect of CB. Notwithstanding the increased evidence for a crosstalk between cAMP and the ERK/MAPK pathway [22], Erk expression was not modified by exposure to CB. It is therefore most likely that decreased cell cycling is promoted through PKA/CREB signaling, as proposed by others [23].
###end p 40
###begin p 41
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Kozar1">[21]</xref>
###xml 263 272 263 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1/Waf1</sup>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Steinman1">[26]</xref>
###xml 411 415 411 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Cheng2">[27]</xref>
###xml 648 652 648 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Coats1">[28]</xref>
###xml 737 746 737 746 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1/Waf1</sup>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Steinman1">[26]</xref>
H4R stimulation resulted in a striking downregulation of cyclin D3, whose expression is typically induced by mitogens [21]. Cyclin E levels were likewise decreased, while CB prevented the growth factor-induced decrease of the cyclin-dependent kinase inhibitor p21Cip1/Waf1, a cell cycle regulator with important functions in self-renewal, differentiation and apoptosis of progenitor cells [26]. By contrast, p27Kip1 expression that has been associated with the regulation of growth and/or differentiation of more lineage-restricted progenitor cells [27] was decreased in the same conditions. It is currently acknowledged that the suppression of p27Kip1 alone is not sufficient to induce hematopoietic progenitor cell cycling [28], as p21Cip1/Waf1 presumably compensates for its loss to maintain quiescence [26].
###end p 41
###begin p 42
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 76 83 76 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 557 564 557 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 902 906 902 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Botnick1">[29]</xref>
###xml 1049 1053 1049 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Mulder1">[30]</xref>
###xml 1165 1169 1165 1169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Gabrilove1">[31]</xref>
###xml 1171 1175 1171 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Moore1">[32]</xref>
###xml 1619 1623 1619 1623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Hornung1">[33]</xref>
###xml 1625 1629 1625 1629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Nagler1">[34]</xref>
###xml 93 99 <span type="species:ncbi:10090">murine</span>
The growth arrest in response to H4R stimulation occurred both in vitro and in vivo. Indeed, murine progenitor-enriched bone marrow cells recovered after injection of CB were less prompt to enter the cell cycle in response to growth factor cocktail than saline-injected controls. This cell cycle arrest was revealed only when progenitors were induced to proliferate in response to growth factors. Without stimulation, they were mostly quiescent, and thus not affected by H4R activation. The reversibility of the cell cycle arrest, the lack of apoptosis and in vivo toxicity qualified H4R agonists as potential pharmacological tools to protect clonogenic cells from the hematotoxicity of anti-cancer drugs, which remains a major drawback of chemotherapy. This toxicity can affect either all hematopoietic lineages or particular subsets, depending on the anti-cancer drug used and the doses administered [29]. Several approaches have been proposed to limit these complications, such as autologous bone marrow transplantation at high-dose chemotherapy [30] or treatment with growth factors like G-CSF or Epo to alleviate neutropenia or to prevent anemia, respectively [31], [32]. Yet, despite their relative effectiveness in accelerating hematopoietic recovery or allowing a more intensive drug regimen, these treatments are expensive, difficult to handle and not devoid of side effects. There is also some evidence that repeated treatment with growth factors during multiple courses of chemotherapy may deplete the stem cell compartment and give rise to genomic alterations, even though these issues remain controversial [33], [34].
###end p 42
###begin p 43
###xml 245 249 245 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Phillips1">[35]</xref>
###xml 303 311 303 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 325 332 325 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Mass1">[36]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Santini1">[37]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Guest1">[38]</xref>
###xml 629 637 629 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 642 649 642 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Broxmeyer1">[39]</xref>
###xml 318 324 <span type="species:ncbi:10090">murine</span>
The use of negative regulators of hematopoietic progenitor proliferation as a strategy to reduce the hematotoxicity of anti-neoplastic drugs, while improving the anti-tumor activity by dose intensification, has been proposed in previous studies [35]. Some of these compounds have proved quite effective in vitro or in murine in vivo models [36]-[37], but turned out to be less beneficial in preclinical trials because of a number of side effects [38]. It has also been reported that chemokines act in synergy to decrease the percentage of progenitors in S phase, thus providing myeloprotection against cell cycle-dependent drugs in vitro and in vivo and accelerating hematopoietic recovery [39]. It has not yet been established whether this effect is direct or indirect and how chemokine receptors are distributed on different hematopoietic progenitor subsets.
###end p 43
###begin p 44
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Rivera1">[40]</xref>
###xml 481 482 481 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Cianchi1">[24]</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Medina1">[25]</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Medina2">[41]</xref>
###xml 573 577 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Boer1">[42]</xref>
###xml 869 877 869 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Among the multiple biological activities ascribed to histamine, its contribution to the regulation of cell proliferation is supported by a number of reports in normal and tumor cells [40]. These studies have produced numerous and often conflicting results, probably because histamine exerts different effects depending on its binding sites and their distribution on target cells. Although it is generally acknowledged that H4Rs are mainly expressed in hematopoietic cells, some H4R+ tumor cell lines and colorectal cancer biopsies have also been reported [24], [25], [41], [42]. We failed to confirm this result in the colon carcinomas, HT29 and HCT116, and the mammary carcinoma MDA-MB-231. In accordance with the lack of expression, we found that the H4R agonist CB affected neither the proliferation of these malignant cells nor did it decrease their sensitivity to in vitro treatment with the antineoplastic drug 5-FU, which raises the question of the reliability of results obtained with long-established cell lines.
###end p 44
###begin p 45
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Medina1">[25]</xref>
###xml 661 665 661 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Medina2">[41]</xref>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Boer1">[42]</xref>
###xml 99 106 <span type="species:ncbi:9606">patient</span>
It is obvious that in a clinical setting H4R expression in cancer cells should be assessed in each patient before treatment and avoided when positive. Note that the studies investigating the effect of H4R activation on cancer cell cycle progression have given rise to conflicting results so far. For example, in MDA-MB-231 cells H4R activation has been shown to result in G0/G1 cell cycle arrest followed by apoptosis [25], while in another report histamine receptor-mediated cell cycle arrest occurred in G2/M, once again followed by apoptosis and enhanced radio-sensitivity, which would increase the therapeutic efficiency rather than protect malignant cells [41]. It has also been proposed that H4R expression is downregulated in colorectal tumour cells [42], as compared with healthy tissue, which underscores once again the requirement of individual tests.
###end p 45
###begin p 46
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Bertolini1">[43]</xref>
In conclusion, our data provide evidence for a new site of intervention of histamine, through which it can specifically slow down cell cycle progression in hematopoietic progenitors. At this point, we can only speculate on the physiological relevance of this interaction in patho-physiological situations generating increased histamine levels in hematopoietic organs. Nonetheless, this new function of the H4R provides an original therapeutic strategy to alleviate the side effects of chemotherapy by preventing clonogenic progenitors from entering the cell cycle, rendering them less susceptible to the toxicity of anti-cancer drugs. We have not established so far whether the H4R is functional in hematopoietic stem cells with long-term repopulation activity, which in any case would be irrelevant in this particular context, because this quiescent population is not affected by cell cycle-dependent drugs [43]. The purpose of our approach is to limit the period of aplasia by accelerating short-term reconstitution from more lineage-restricted clonogenic progenitors without impairing the sensitivity of cancer cells to the treatment. These clinical perspectives, which might eventually facilitate chemotherapy dose and schedule intensification, call for the development of new, selective H4R agonists.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
Ethics statement
###end title 48
###begin p 49
Animal experiments were performed according to the French Institutional Committee.
###end p 49
###begin p 50
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 281 282 281 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CD34+ cells were purified from cord blood recovered with the parents' written consent, in accordance with the recommendations and approval of the Belgian Ethical Committee (Comite ethique hospitalo-facultaire universitaire Liege 707). The experiments were with frozen purified CD34+ cells in the research unit CNRS UMR8147 were performed with the approval of the local Ethics Committee (Comite d'ethique de l'Hopital Necker).
###end p 50
###begin title 51
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 51
###begin p 52
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
6- to 8-week-old, specific pathogen-free, male or female C57BL/6J mice were purchased from CERJ (Les Genest St. Isle, France) and maintained in our animal facility. All mice were kept in well-controlled animal housing facilities and had free access to tap water and pellet food. Animal experiments were performed according to the French Institutional Committee.
###end p 52
###begin title 53
Cytokines, histamine receptor ligands, antibodies and other compounds
###end title 53
###begin p 54
###xml 458 460 458 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1191 1211 1186 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 511 516 <span type="species:ncbi:10090">Mouse</span>
###xml 665 670 <span type="species:ncbi:10090">mouse</span>
###xml 852 857 <span type="species:ncbi:9606">human</span>
###xml 918 922 <span type="species:ncbi:9925">goat</span>
###xml 928 933 <span type="species:ncbi:9606">human</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
###xml 958 964 <span type="species:ncbi:9793">donkey</span>
###xml 970 974 <span type="species:ncbi:9925">goat</span>
###xml 1036 1040 <span type="species:ncbi:9925">goat</span>
###xml 1191 1211 <span type="species:ncbi:520">Bordetella pertussis</span>
Murine and human recombinant IL-3, IL-6, Flt3-L, GM-CSF and SCF were purchased from R&D Systems (Abingdon, UK). Thioperamide, histamine dihydrochloride, forskolin, dibutyryl (db)cAMP and the PKA inhibitor Rp-8-Br-cAMPS were purchased from Sigma-Aldrich (St.-Quentin Fallavier, France). The H4R agonist clobenpropit dihydrobromide was from Tocris (Ellisville, MO), as was the H4R antagonist JNJ10191585. JNJ7777120 was provided by UCB-Pharma. TrueLabeling-AMPTM Linear RNA Amplification Kit and Oligo GEArray(R) Mouse cell cycle Microarray (OMM-020) were purchased from SABiosciences (tebu-bio, France) The following appropriately labeled antibodies were used: anti-mouse CD117 (c-kit) (2B8), TCRbeta (H57-597), Ly-6G(Gr-1) (RB6-8C5), CD11b (M1/70), CD45R(B220) (RA3-6B2), CD4 (H129.19), CD8 (53-6.7), CD19 (1D3), TER-119, Ly-6A/E (Sca-1) (D7) and anti-human CD34 (581) (all from Pharmingen, San Diego, CA). Polyclonal goat anti-human and anti-mouse H4R Abs, donkey anti-goat-FITC, corresponding blocking peptides and irrelevant control goat Abs were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). FITC-conjugated anti-cyclin D3 and isotype controls were likewise from Santa Cruz. Bordetella pertussis toxin was from Calbiochem (La Jolla, CA).
###end p 54
###begin title 55
Cell preparations, FACS analysis and sorting
###end title 55
###begin p 56
###xml 101 104 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006504-Schneider2">[5]</xref>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Bone marrow and spleen cells were recovered and suspended in culture medium, as previously described [5]. Peripheral blood was collected from the retro-orbital sinus and nucleated cells were counted on a MS9-5 Hematology Counter (Melet Schloesing Laboratories, Osny, France). CD34+ cells were purified from cord blood recovered with the parents' consent, in accordance with the recommendations of the Belgian Ethical Committee. They were sorted magnetically using the positive selection kit purchased from Miltenyi (Bergisch-Gladbach, FRG).
###end p 56
###begin p 57
###xml 99 100 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 58 61 <span type="species:ncbi:10116">rat</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Cell suspensions were incubated on ice in the presence of rat anti-mouse CD16/CD32 mAb (1 microg/106 cells, Pharmingen) to block Fc receptor functions prior to specific staining with appropriately labeled antibodies. For intracellular labeling with anti-H4R and anti-cyclin D3 antibodies cells were treated with FACS permeabilizing solution from BD before staining Cells were analyzed in a FACSCanto II cytofluorometer (Becton Dickinson, Mountain View, CA), using FlowJo software. Erythrocytes and debris were excluded on the basis of forward and side scatter parameters. At least 10,000 cells were acquired within the live gate.
###end p 57
###begin p 58
###xml 3 4 3 4 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 156 157 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 167 168 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 356 357 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 361 362 358 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 423 425 420 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
Lin- cells designate a progenitor-enriched population expressing neither myeloid nor lymphoid lineage markers (negative for CD11b, Gr-1, CD19, TCRbeta). Lin- and c-kit+ cells (>95% purity) were isolated using the SpinSep depletion kit and the positive selection kit with the RoboSep automaton from StemCell Technologies, respectively. After staining, c-kit+Sca1+ cells were further sorted electronically using a FACSVantageTM cell sorter (Becton Dickinson). The effect of CB on apoptosis of progenitor-enriched BMC was evaluated using an Annexin-V staining kit (Pharmingen). All these reagents were used according to the manufacturer's instructions.
###end p 58
###begin title 59
Cell cultures
###end title 59
###begin p 60
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 31 32 31 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 283 285 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
Progenitor-enriched Lin-, c-kit+ or CD34+ cells were suspended at a final concentration of 105 cells per ml in serum-free StemSpan medium (StemCell Technologies) and cultured up to 3 days in the presence of 10 ng of IL-3, 10 ng of IL-6 and 50 ng of SCF per ml, with or without CB (10-5 M). They were examined at different time points for cell cycle progression as well as phenotypic and morphologic characteristics, using cytometry and light microscopy analysis of MGG-stained cytospin preparations.
###end p 60
###begin p 61
###xml 269 270 269 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 337 338 337 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 427 435 427 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 577 578 577 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 596 598 596 598 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 653 655 649 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 317 323 <span type="species:ncbi:10090">murine</span>
###xml 352 357 <span type="species:ncbi:9606">human</span>
###xml 672 678 <span type="species:ncbi:10090">murine</span>
Murine CFU-GM and human CFU-C were quantified in MethoCult M3230 (StemCell Technologies) supplemented with IL-3 alone (1 ng/ml) and in MethoCult GF H4434 (complete with growth factors), respectively. They were plated in a final volume of 1 ml at a concentration of 5x104 total BM cells/culture dish (Falcon 1008) for murine and 5000 CD34+ cells/ml for human progenitors. Colonies were scored on day 7 and day 14, respectively. In vitro protection against myelotoxic AraC (Cytarabine, Pfizer) and hydroxy-urea (Sigma) was evaluated after a 24-h pretreatment of total BMC or CD34+ cells with CB (10-5 M), followed by exposure to 10 microg/ml of AraC or 10-3 M hydroxy-urea (murine) for 1 h, extensive washing and colony-forming assay.
###end p 61
###begin p 62
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
In some experiments clonogenic progenitors were evaluated in the HALOTM-Hemogenix assay (Hemogenix Inc., Colorado Springs, CA) based on luminescence output using adequate growth factor cocktails for CFU-GEMM, CFU-GM and BFU-E colony formation, according to the manufacturer's instructions.
###end p 62
###begin p 63
###xml 267 268 261 262 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 115 121 <span type="species:ncbi:10090">murine</span>
Clonogenic common lymphoid progenitors were evaluated in MethoCult M3230 (StemCell Technologies) supplemented with murine recombinant SCF (100 ng/ml), IL-7 (10 ng/ml and Flt-3-L (20 ng/ml). All cultures were incubated at 37degreesC in a humidified chamber under 5% CO2.
###end p 63
###begin title 64
Tracking of cell divisions and evaluation of cell cycle status
###end title 64
###begin p 65
###xml 2 3 2 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 348 350 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 468 469 462 463 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
105 Lin- BMC/ml were incubated at 37degreesC with 5 mM CFSE (Invitrogen) in PBS. After 10 min, a 5-fold excess of ice-cold PBS was added to stop the reaction. Cells were then centrifuged, re-suspended and cultured for 72 h in serum-free StemSpan medium supplemented with IL-3, IL-6 and SCF (10, 10 and 50 ng/ml, respectively, with or without CB (10-5 M). Thereafter, they were labeled with APC-conjugated anti-c-kit antibody and CFSE fluorescence was analyzed in c-kit+ cells.
###end p 65
###begin p 66
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 313 314 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 423 425 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 442 444 434 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 462 464 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 631 651 623 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bordetella pertussis</italic>
###xml 631 651 <span type="species:ncbi:520">Bordetella pertussis</span>
After incubation, 105 cells were labeled with FITC-conjugated c-kit antibody, fixed in PBS 1% formaldehyde-free methanol that was removed before treatment with 1 ml of PI/Triton X100 (20 microg/ml/0.1%)+DNase-free RNase (0.2 microg/ml) for 30 min at room temperature. In some experiments magnetically sorted c-kit+ BMC were incubated for 2 h in StemSpan medium with growth factor cocktail alone or in the presence of CB (10-5 M), dbcAMP (5x10-4 M), forskolin (10-5 M) with or without CB. The cell cycle status was then assessed using Vybrant DyeCycle Violet (VDV) Stain, according to the manufacturer's instructions. The effect of Bordetella pertussis toxin (100 ng/ml) on the cell cycle arrest promoted by CB was evaluated in the same conditions. After incubation, cells were analyzed using FlowJo sofware.
###end p 66
###begin title 67
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo experiments
###end title 67
###begin p 68
###xml 245 246 245 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 400 401 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
The cell cycle status of bone marrow CFU-C was analyzed after three i.p. injections of CB at a concentration of 30 mg/kg each at 24, 16 and 4 h before sacrifice. Bone marrow cells were then recovered, incubated overnight at a concentration of 106 cells/ml in growth factor cocktail (10 ng of IL-3, 10 ng of IL-6 and 50 ng of SCF per ml) followed by PI staining and cell cycle analysis among gated Lin- cells.
###end p 68
###begin p 69
###xml 145 149 <span type="species:ncbi:10090">Mice</span>
###xml 362 366 <span type="species:ncbi:10090">Mice</span>
The myeloprotective effect of CB-induced cell cycle arrest was assessed after treatment with AraC or cyclophosphamide (Endoxan: Baxter, France). Mice received three i.p. injections of CB at a dose of 20 mg/kg, at 24 and 4 h before, as well as 24 h after chemotherapy. AraC and cyclophosphamide were given i.p. at a dose of 350 mg/kg and 300 mg/kg, respectively. Mice were sacrificed on day 2 post-chemotherapy, when white blood cells were counted and colony-forming cells were evaluated in methylcellulose in response to IL-3.
###end p 69
###begin title 70
Western blotting, cell cycle microarray and H4R silencing
###end title 70
###begin p 71
###xml 85 86 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 771 779 763 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Waf1/Cip</sup>
###xml 839 843 831 835 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 931 932 921 922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1087 1089 1077 1079 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1322 1323 1312 1313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1347 1348 1337 1338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1794 1795 1764 1765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1977 1978 1947 1948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 2044 2045 2014 2015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2054 2055 2024 2025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1460 1465 <span type="species:ncbi:9606">human</span>
###xml 1492 1498 <span type="species:ncbi:10090">murine</span>
Whole-cell extracts for Western blot analysis were prepared from freshly sorted c-kit+ cells after a 5-h incubation in StemSpan medium with growth factors alone or together with CB. 30 microg extracts were prepared from washed cells in 100 microl extraction buffer. They were subjected to SDS-PAGE and transferred onto nitrocellulose sheets (Hybond C, Amersham Biosciences). Protein transfer was ascertained by Ponceau red coloration. Membranes were then washed with PBS and blocked with PBS-Tween 0.1%-gelatin 0.5% for 1 h at room temperature. Blotting with monoclonal anti-cyclin E antibodies (Santa Cruz Biotechnology) was performed according to the manufacturer's instructions. The same membranes were then stripped and reprobed with monoclonal antibodies against p21Waf1/Cip, p-Erk1/2, Erk 1/2, actin (Santa Cruz Biotechnology) or p27Kip1 (Pharmingen). Oligo GEArray(R) assays were performed with freshly isolated sorted c-kit+ BM cells or after a 3-h incubation in the presence of growth factor cocktail with or without CB. RNA was extracted and amplified with the TrueLabeling-AMPTM Linear RNA Amplification kit according to the manufacturer's instructions. The array OMM-20 contains 128 oligonucleotide probes representing genes associated with the cell cycle. H4R silencing was performed with freshly sorted c-kit+ cells and expanded CD34+ cells. For transfection, 3 microl of HiPerFect reagent (Qiagen; Courtaboeuf, France) and 4 microl (40 pmol) of human and 8 microl (80 pmol) of murine H4R siRNA, scrambled FITC-labeled or unconjugated control siRNAs (all from Santa Cruz Biotechnology) were incubated in 50 microl x-vivo medium (Cambrex; East Rutherford, NJ) for 20 min at room temperature. The mixture was then added to 50 microl of cell suspension at a final concentration of 106 cells/ml and incubated for 20 h, when transfection efficiency was verified with scrambled FITC-conjugated siRNA. Cells were then centrifuged and resuspended at a concentration of 105 cells/ml in StemSpan medium with growth factor cocktail for c-kit+ and CD34+ cells. The extinction of H4R protein expression was ascertained by FACS analysis after 24 h. After 3 days of culture with or without CB, cells were counted and their viability was assessed by trypan blue exclusion. The cell cycle status was assessed after an overnight incubation.
###end p 71
###begin title 72
Statistics
###end title 72
###begin p 73
Statistical significance was established by Student's and Mann-Whitney's two-tailed t test.
###end p 73
###begin title 74
Supporting Information
###end title 74
###begin p 75
Dose response curve of cell cycle arrest induced by CB.
###end p 75
###begin p 76
(6.01 MB TIF)
###end p 76
###begin p 77
Click here for additional data file.
###end p 77
###begin p 78
Apoptosis was evaluated by Annexin-V/PI staining after a 3-day incubation of progenitor-enriched Lin- BMC in the presence of growth factor cocktail, with or without CB (10-5 M). A typical experiment is depicted.
###end p 78
###begin p 79
(6.01 MB TIF)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
Blockade of H4R by specific antagonists abrogates CB-induced cell cycle arrest. Cell cycle was analyzed after VDV staining in sorted progenitor-enriched c-kit+ BM cells after a 2-h incubation in StemSpan medium supplemented growth factor cocktail (GF), with or without CB at a concentration of 10-5 M. The H4R antagonists were added at a concentration of 10-5 M 10 min before CB.
###end p 81
###begin p 82
(6.01 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin title 84
Acknowledgements
###end title 84
###begin p 85
The authors thank Dr. O. Hermine for critical reading of the manuscript and Dr. K. Zinkewich-Peotti (UCB-PHARMA) for participating in the discussion of this work. This study was carried out with the technical assistance of M. Levasseur and R. Bricard.
###end p 85
###begin title 86
References
###end title 86
###begin article-title 87
Trends in histamine research: new functions during immune responses and hematopoiesis.
###end article-title 87
###begin article-title 88
Histamine-cytokine connection in immunity and hematopoiesis.
###end article-title 88
###begin article-title 89
Immune regulation by histamine.
###end article-title 89
###begin article-title 90
Genomics meets histamine receptors: new subtypes, new receptors.
###end article-title 90
###begin article-title 91
###xml 39 45 <span type="species:ncbi:10090">murine</span>
Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels.
###end article-title 91
###begin article-title 92
Interaction of histamine and other bioamines with cytochromes P450: implications for cell growth modulation and chemopotentiation by drugs.
###end article-title 92
###begin article-title 93
Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors.
###end article-title 93
###begin article-title 94
Recent advances in molecular pharmacology of the histamine systems: regulation of histamine H1 receptor signalling by changing its expression level.
###end article-title 94
###begin article-title 95
Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow.
###end article-title 95
###begin article-title 96
###xml 42 47 <span type="species:ncbi:9606">human</span>
Histamine induces cytoskeletal changes in human eosinophils via the H4 receptor.
###end article-title 96
###begin article-title 97
Histamine H4 receptor mediates eosinophil chemotaxis with cell shape change and adhesion molecule up-regulation.
###end article-title 97
###begin article-title 98
Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells.
###end article-title 98
###begin article-title 99
Critical role of histamine H4 receptor in leukotriene B4 production and mast cell-dependent neutrophil recruitment induced by zymosan in vivo.
###end article-title 99
###begin article-title 100
###xml 92 97 <span type="species:ncbi:9606">human</span>
Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells.
###end article-title 100
###begin article-title 101
###xml 84 89 <span type="species:ncbi:9606">human</span>
Histamine H4 and H2 receptors control histamine-induced interleukin-16 release from human CD8+ T cells.
###end article-title 101
###begin article-title 102
The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+ T cells.
###end article-title 102
###begin article-title 103
The histamine H4 receptor as a new therapeutic target for inflammation.
###end article-title 103
###begin article-title 104
Mechanism for histamine H2-receptor induced cell-cycle changes in the bone marrow stem cell.
###end article-title 104
###begin article-title 105
New role for histamine in interleukin-3 induced proliferation of hematopoietic stem cells.
###end article-title 105
###begin article-title 106
A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties.
###end article-title 106
###begin article-title 107
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse development and cell proliferation in the absence of D-cyclins.
###end article-title 107
###begin article-title 108
Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation.
###end article-title 108
###begin article-title 109
CREB is a critical regulator of normal hematopoiesis and leukemogenesis.
###end article-title 109
###begin article-title 110
The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer.
###end article-title 110
###begin article-title 111
###xml 25 30 <span type="species:ncbi:9606">human</span>
The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
###end article-title 111
###begin article-title 112
Cell cycle regulators and hematopoiesis.
###end article-title 112
###begin article-title 113
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kip1</sup>
Stem cell repopulation efficiency but not pool size is governed by p27kip1.
###end article-title 113
###begin article-title 114
A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
###end article-title 114
###begin article-title 115
Differential effects of cytotoxic agents on hematopoietic progenitors.
###end article-title 115
###begin article-title 116
High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
###end article-title 116
###begin article-title 117
###xml 71 78 <span type="species:ncbi:9606">patient</span>
Cancer therapy: New strategies and treatment modalities for optimizing patient outcome.
###end article-title 117
###begin article-title 118
Clinical implications of positive and negative hematopoietic stem cell regulators.
###end article-title 118
###begin article-title 119
Hematopoietic stem cell depletion by restorative growth factor regimens during repeated high-dose cyclophosphamide therapy.
###end article-title 119
###begin article-title 120
Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells.
###end article-title 120
###begin article-title 121
Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy.
###end article-title 121
###begin article-title 122
###xml 64 68 <span type="species:ncbi:10090">mice</span>
The tetrapeptide Acetyl-N-Ser-Asp-Lys Pro (Goralatide) protects mice from doxorubicin-induced toxicity: an improvement in both survival and hematological protection for early marrow stem cells and progenitors.
###end article-title 122
###begin article-title 123
Amifostine: chemotherapeutic and radiotherapeutic protective effects.
###end article-title 123
###begin article-title 124
Bone marrow stem cell protection from chemotherapy by low-molecular-weight compounds.
###end article-title 124
###begin article-title 125
###xml 166 170 <span type="species:ncbi:10090">mice</span>
Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.
###end article-title 125
###begin article-title 126
Histamine as an autocrine growth factor: an unusual role for a widespread mediator.
###end article-title 126
###begin article-title 127
###xml 40 45 <span type="species:ncbi:9606">human</span>
Histamine-mediated signaling process in human malignant mammary cells.
###end article-title 127
###begin article-title 128
###xml 98 103 <span type="species:ncbi:9606">human</span>
Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumors by histamine.
###end article-title 128
###begin article-title 129
Multilineage long-term engraftment potential of drug-resistant hematopoietic progenitors.
###end article-title 129
###begin p 130
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: Authors P. Chatelain and P. Mistry were employed by UCB-Pharma at the time of the research being conducted.
###end p 130
###begin p 131
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was partially funded by UCB-Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The laboratory is mainly financed by the CNRS.
###end p 131

